SV

Street Verdict

Analyst Scorecard

A record of what Raja Venkataraman said publicly, with the source. Not advice.

“Bullish on Medplus Health Services (MEDPLUS), recommending a buy at current market price and on dips to ₹760, with a 3-month target of ₹865-885 and a stop loss at ₹745. The call is supported by gradual accumulation at critical support levels, strong investor interest, and consistent revenue growth, despite competition in the retail pharmacy space and margin pressure.”

Raja Venkataraman’s track record (trackable calls only): 5 graded calls · 95% CI 23–88%

Medplus Health ServicesBullishCalled 15 Apr 2025Graded 16 May 2025
Verdict:HIT

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

No entry price is stated, so the call starts at the first close after it was published.

Target ₹865, stop ₹745, as stated.

Window: 90 days, the time frame the call states ("3-month").

The target ₹865 was reached on a close before the stop ₹745. Hit.

The grader’s working: R4 TARGET_CALL: entered ₹790.4 on 2025-04-16 (next trading session's close); target ₹865 reached at close ₹885.55 on 2025-05-16. Window 90 days — rule H1: the quote states "3-month".

Tracking Medplus Health Services since this call

1-year tracking window
Read the original articleSee Raja Venkataraman’s full track record